Published in Neuropeptides on December 01, 2003
Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry (2005) 1.16
Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology (2006) 0.94
Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers. Front Psychol (2014) 0.82
Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal. Br J Pharmacol (2014) 0.80
Relationship between status of plasma atrial natriuretic peptide and heart rate variability in human subjects. Heart Vessels (2012) 0.79
Natriuretic hormones in brain function. Front Endocrinol (Lausanne) (2014) 0.79
Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. Am J Cardiol (2009) 0.79
[Psychosomatic aspects of chronic heart failure. Nothing but depression?]. Herz (2011) 0.76
Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome. Sci Rep (2017) 0.75
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest (2003) 3.62
Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage (2007) 2.73
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry (2003) 1.73
Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry (2013) 1.71
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry (2012) 1.70
Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry (2004) 1.63
Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry (2011) 1.56
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry (2002) 1.56
Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharmacology (Berl) (2002) 1.49
Exercise and physical activity in mental disorders: clinical and experimental evidence. J Prev Med Public Health (2013) 1.29
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Heritability of sleep electroencephalogram. Biol Psychiatry (2008) 1.19
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res (2005) 1.18
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17
Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol (2011) 1.17
Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry (2011) 1.14
Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol (2002) 1.14
Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis (2005) 1.12
Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology (Berl) (2014) 1.12
Altered representation of expected value in the orbitofrontal cortex in mania. Hum Brain Mapp (2010) 1.10
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord (2009) 1.08
Delineating self-referential processing from episodic memory retrieval: common and dissociable networks. Neuroimage (2010) 1.08
Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry (2009) 1.07
Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab (2007) 1.07
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One (2011) 1.07
D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial. J Psychiatr Res (2011) 1.06
Are obese adolescents and young adults at higher risk for mental disorders? A community survey. Obes Res (2002) 1.05
Reward processing in male adults with childhood ADHD--a comparison between drug-naïve and methylphenidate-treated subjects. Psychopharmacology (Berl) (2011) 1.03
Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res (2006) 1.01
Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS One (2010) 1.01
Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment? Biol Psychiatry (2006) 1.01
Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology (2006) 1.00
Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology (2009) 0.99
Exercise and physical activity in mental disorders. Eur Arch Psychiatry Clin Neurosci (2011) 0.98
5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls. Psychopharmacology (Berl) (2009) 0.97
Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res (2009) 0.97
Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage. Cerebrovasc Dis (2010) 0.96
The facial pattern of disgust, appetence, excited joy and relaxed joy: an improved facial EMG study. Scand J Psychol (2005) 0.95
Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol (2011) 0.95
Random sampling for a mental health survey in a deprived multi-ethnic area of Berlin. Community Ment Health J (2012) 0.95
The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives. Int J Geriatr Psychiatry (2008) 0.95
Creating probabilistic maps of the face network in the adolescent brain: a multicentre functional MRI study. Hum Brain Mapp (2011) 0.94
Exercise and physical activity in the therapy of substance use disorders. ScientificWorldJournal (2012) 0.94
Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res (2005) 0.93
Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. J Psychiatr Res (2006) 0.93
Central serotonin transporter levels are associated with stress hormone response and anxiety. Psychopharmacology (Berl) (2010) 0.92
Optimization of 3-dimensional imaging of the breast region with 3-dimensional laser scanners. Ann Plast Surg (2006) 0.92
A preliminary study of increased amygdala activation to positive affective stimuli in mania. Bipolar Disord (2009) 0.91
Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression. BMC Neurosci (2011) 0.91
Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2012) 0.90
The organization of autobiographical and nonautobiographical memory in posttraumatic stress disorder (PTSD). J Abnorm Psychol (2009) 0.90
Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology (Berl) (2002) 0.90
Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology (2011) 0.90
Verbal and nonverbal memory functioning in posttraumatic stress disorder (PTSD). J Clin Exp Neuropsychol (2006) 0.90
Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PLoS One (2012) 0.90
Impact of childhood trauma on hypothalamus-pituitary-adrenal axis activity in alcohol-dependent patients. Eur Addict Res (2010) 0.90
Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol (2003) 0.89
Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Mov Disord (2002) 0.89
Use of proteomic methods in the analysis of human body fluids in Alzheimer research. Electrophoresis (2012) 0.89
Is salivary alpha-amylase an indicator of autonomic nervous system dysregulations in mental disorders?--a review of preliminary findings and the interactions with cortisol. Psychoneuroendocrinology (2013) 0.89
Association of leptin with food cue-induced activation in human reward pathways. Arch Gen Psychiatry (2012) 0.89
Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J Gerontol A Biol Sci Med Sci (2003) 0.88
Words may not be enough! No increased emotional Stroop effect in obsessive-compulsive disorder. Behav Res Ther (2008) 0.88
Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res (2011) 0.88
The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology (2011) 0.88
An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology (2011) 0.88
Ghrelin levels increase after pictures showing food. Obesity (Silver Spring) (2012) 0.87
Childhood methylphenidate treatment of ADHD and response to affective stimuli. Eur Neuropsychopharmacol (2010) 0.87
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology (Berl) (2004) 0.87
Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking. JAMA Psychiatry (2013) 0.87
Dimensional structure of the Hamilton Depression Rating Scale in patients with obsessive-compulsive disorder. Psychiatry Res (2004) 0.87
Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol (2005) 0.86
Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. J Psychiatr Res (2010) 0.86
Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology (2011) 0.86
Association between childhood trauma and low hair cortisol in depressed patients and healthy control subjects. Biol Psychiatry (2013) 0.86
Cortisol response to experimental pain in patients with chronic low back pain and patients with major depression. Pain Med (2012) 0.86
Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet (2012) 0.85
Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse. J Psychiatr Res (2009) 0.85